Fundz

Alto Neuroscience reported raising $59.3 Million in an initial SEC Form D filing, from an offering of $59.3 Million

PUBLIC · ANRONov 27, 2023Late filing, first sale Apr 6, 2022

Amount Raised

$59.3 Million

$59.3 Million sold, per SEC Form D (first sale Apr 6, 2022)

Round Type

Venture

Mountain ViewBiotechnologyHealth Care

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Alto Neuroscience that raised within 45 days of this round, from Fundz verified event records.

  • Nuo Therapeutics raised $408K (Seed) on May 19, 2022.
  • Inceptor Bio raised $37M (Series A) on May 19, 2022.
  • Vyriad raised $30M (Series B) on May 17, 2022.
  • WaveFront Dynamics Inc. raised $1.2M (Seed) on May 17, 2022.
  • Impulse Dynamics raised $101M (Funding Round) on May 12, 2022.
  • GE HealthCare Technologies raised an undisclosed amount (Corporate Round) on May 12, 2022.

Who to call at Alto Neuroscience, and when

A new round usually means Alto Neuroscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Alto Neuroscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alto Neuroscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alto Neuroscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alto Neuroscience

Location

650 Castro Street, Suite 450

Mountain View, California, United States

About

Alto Neuroscience is a biopharmaceutical company redefining psychiatry through its Precision Psychiatry Platform™, which leverages individuals’ neurobiology to develop personalized and highly effective medicines that help patients get better faster. By integrating biomarkers such as EEG and wearable data, behavioral patterns, genetics, and other biological factors, Alto uses AI-driven insights to match each patient with the treatment they are most likely to respond to—bringing a new era of precision and effectiveness to mental health care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alto Neuroscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsPatricio O., VP of Translational Medicine hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Alto Neuroscience's next move

See what Strategic adds

Alto Neuroscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.